IRIS
MACCARONI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.171
EU - Europa 1.392
AS - Asia 1.052
SA - Sud America 195
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 86
OC - Oceania 2
Totale 5.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.121
IT - Italia 349
SG - Singapore 333
CN - Cina 241
RU - Federazione Russa 180
VN - Vietnam 169
UA - Ucraina 163
BR - Brasile 153
DE - Germania 128
SE - Svezia 116
IE - Irlanda 99
HK - Hong Kong 76
TR - Turchia 76
FI - Finlandia 68
FR - Francia 67
DK - Danimarca 63
GB - Regno Unito 59
CI - Costa d'Avorio 42
IN - India 36
KR - Corea 33
BD - Bangladesh 31
CA - Canada 27
PL - Polonia 26
MA - Marocco 23
NL - Olanda 18
AR - Argentina 16
JP - Giappone 15
ZA - Sudafrica 15
MX - Messico 14
ES - Italia 13
BE - Belgio 11
EC - Ecuador 8
CO - Colombia 6
AT - Austria 5
CZ - Repubblica Ceca 5
PH - Filippine 5
PK - Pakistan 5
IQ - Iraq 4
RO - Romania 4
CL - Cile 3
DZ - Algeria 3
ID - Indonesia 3
JM - Giamaica 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
SA - Arabia Saudita 3
SC - Seychelles 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PT - Portogallo 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 5.907
Salva come PNG Salva come JPEG
Città #
Ashburn 544
Chandler 271
Singapore 211
San Jose 205
Fairfield 176
Jacksonville 174
Dallas 127
New York 102
Council Bluffs 101
Dublin 99
Boardman 93
Wilmington 89
Ann Arbor 80
Woodbridge 80
Centro 74
Beijing 71
Hong Kong 71
Houston 70
Seattle 66
Los Angeles 63
Cambridge 56
Hanoi 52
Ho Chi Minh City 51
Moscow 47
Abidjan 42
Munich 42
Des Moines 40
Lawrence 38
Princeton 38
San Mateo 36
Lauterbourg 33
The Dalles 33
Turin 31
Turku 28
Orem 25
Warsaw 25
Milan 24
Chicago 23
Ancona 19
Rome 19
Buffalo 18
Hefei 16
San Diego 16
Santa Clara 16
Atlanta 13
Helsinki 13
London 13
Tokyo 13
Johannesburg 12
Brooklyn 11
Montreal 11
Pune 11
Brussels 10
Phoenix 10
São Paulo 10
Amsterdam 8
Chennai 8
Miano 8
Poplar 8
Salt Lake City 8
Da Nang 7
Washington 7
Cagliari 6
Canicattì 6
Elk Grove Village 6
Florence 6
Manchester 6
Mexico City 6
Palermo 6
Rio de Janeiro 6
Stockholm 6
Boston 5
Denver 5
Falconara Marittima 5
Guangzhou 5
Jiaxing 5
Marche 5
New Delhi 5
Olomouc 5
Paris 5
Tampa 5
Wuxi 5
Bari 4
Brasília 4
Columbus 4
Curitiba 4
Frankfurt am Main 4
Haiphong 4
Modena 4
Mumbai 4
New Bedfont 4
Shanghai 4
Sterling 4
Thái Nguyên 4
Toronto 4
Vienna 4
Wuhan 4
Amman 3
Belo Horizonte 3
Birmingham 3
Totale 3.894
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 225
Caratterizzazione istologica e molecolare nelle pazienti con carcinoma ovarico sporadico ed ereditario 220
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 199
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 197
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 195
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 194
Optimal management of resected gastric cancer 189
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. 186
5-Fluorouracil pharmacogenomics: still rocking after all these years? 177
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 177
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 172
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy. 171
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 169
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 169
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 164
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 164
Adjuvant treatment after surgical resection 158
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal? 153
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 152
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 146
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer 146
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 143
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 143
Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2. 142
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 141
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 139
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 137
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 137
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors 136
New Insights into Hormonal Therapies in Uterine Sarcomas 135
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 133
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 128
Transient sunitinib resistance in gastrointestinal stromal tumors. 128
Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1. 114
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 111
Locally advanced rectal cancer: new findings in anticancer therapy 110
Thymic epithelial tumors (TETs) and additional tumors: a single Centre experience 104
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 100
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 87
Totale 5.991
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.810
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022218 0 0 9 5 1 15 17 23 16 43 22 67
2022/2023744 53 99 54 57 53 106 1 49 160 6 89 17
2023/2024405 60 10 29 47 54 115 4 13 1 8 7 57
2024/2025753 107 60 14 14 48 24 88 31 112 53 111 91
2025/20262.280 211 131 142 239 322 166 351 200 168 188 61 101
2026/2027147 71 56 20 0 0 0 0 0 0 0 0 0
Totale 5.991